Shopping Cart
Remove All
Your shopping cart is currently empty
P-gp inhibitor 21 (Compound 56) is a P-glycoprotein (P-gp) transport inhibitor that can reverse P-gp-mediated multidrug resistance (MDR) and demonstrates antitumor efficacy in mouse models, without significant cytotoxicity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | P-gp inhibitor 21 (Compound 56) is a P-glycoprotein (P-gp) transport inhibitor that can reverse P-gp-mediated multidrug resistance (MDR) and demonstrates antitumor efficacy in mouse models, without significant cytotoxicity. |
| In vitro | P-gp inhibitor 21 effectively reduces the proliferation of KBV200 and NCI/ADR-RES cells when used in conjunction with VNR, with IC50 values of 2.4 nM and 27.9 nM, respectively. |
| In vivo | The compound P-gp inhibitor 21, administered at 75 mg/kg via intraperitoneal injection, effectively reduces tumor growth in KBV200 xenografts in BALB/c nude mice, while restoring sensitivity of multidrug-resistant (MDR) tumors to VNR, and shows no significant toxicity. |
| Formula | C27H42N2O4 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.